MedPath
HSA Approval

MICROFLOX-250 TABLET 250 mg

SIN08940P

MICROFLOX-250 TABLET 250 mg

MICROFLOX-250 TABLET 250 mg

September 25, 1996

NAINA MOHAMED & SONS PRIVATE LIMITED

NAINA MOHAMED & SONS PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNAINA MOHAMED & SONS PRIVATE LIMITED
Licence HolderNAINA MOHAMED & SONS PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01MA02

ciprofloxacin

Manufacturer Information

NAINA MOHAMED & SONS PRIVATE LIMITED

MICRO LABS LTD

Active Ingredients

CIPROFLOXACIN HCl EQV CIPROFLOXACIN

250 mg

Ciprofloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MICROFLOX-250 TABLET 250 mg - HSA Approval | MedPath